Blair William & CO Neogenomics Inc Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Neogenomics Inc stock. As of the latest transaction made, Blair William & CO holds 409,182 shares of NEO stock, worth $6.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

409,182

Previous 472,870 13.47%

Holding current value

$6.33 Million

Previous $7.43 Million 23.65%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$13.01 - $15.77 $828,580 - $1 Million	-63,688 Reduced 13.47%	409,182 $5.68 Million
Q1 2024 May 09, 2024	SELL	$14.06 - $16.79 $116,262 - $138,836	-8,269 Reduced 1.72%	472,870 $7.43 Million
Q4 2023 Feb 12, 2024	SELL	$11.67 - $20.73 $300,712 - $534,170	-25,768 Reduced 5.08%	481,139 $7.78 Million
Q3 2023 Nov 09, 2023	SELL	$12.15 - $17.85 $118,608 - $174,251	-9,762 Reduced 1.89%	506,907 $6.23 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $211,528 - $297,489	-15,002 Reduced 2.82%	516,669 $8.3 Million
Q1 2023 May 12, 2023	SELL	$9.09 - $19.45 $398,142 - $851,910	-43,800 Reduced 7.61%	531,671 $9.26 Million
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $148,362 - $277,634	23,002 Added 4.16%	575,471 $5.32 Million
Q3 2022 Nov 09, 2022	BUY	$7.86 - $12.91 $2.07 Million - $3.4 Million	263,037 Added 90.88%	552,469 $4.76 Million
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $357,574 - $707,552	-50,648 Reduced 14.89%	289,432 $2.36 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $183,890 - $533,962	-15,135 Reduced 4.26%	340,080 $4.13 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $181,628 - $288,854	-5,957 Reduced 1.65%	355,215 $12.1 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $608,902 - $767,632	14,616 Added 4.22%	361,172 $17.4 Million
Q2 2021 Aug 12, 2021	BUY	$36.62 - $51.69 $464,048 - $655,015	12,672 Added 3.8%	346,556 $15.7 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $1.8 Million - $2.6 Million	43,404 Added 14.94%	333,884 $16.1 Million
Q4 2020 Feb 09, 2021	SELL	$36.08 - $56.47 $370,252 - $579,495	-10,262 Reduced 3.41%	290,480 $15.6 Million
Q3 2020 Nov 06, 2020	BUY	$33.26 - $40.48 $378,033 - $460,095	11,366 Added 3.93%	300,742 $11.1 Million
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $246,022 - $315,225	10,162 Added 3.64%	289,376 $8.97 Million
Q1 2020 May 11, 2020	SELL	$20.5 - $34.53 $594,520 - $1 Million	-29,001 Reduced 9.41%	279,214 $7.71 Million
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $196,292 - $308,933	-10,353 Reduced 3.25%	308,215 $9.02 Million
Q3 2019 Nov 12, 2019	SELL	$19.12 - $26.24 $271,790 - $373,001	-14,215 Reduced 4.27%	318,568 $6.09 Million
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $959,556 - $1.18 Million	49,032 Added 17.28%	332,783 $7.3 Million
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $89,823 - $151,383	7,399 Added 2.68%	283,751 $5.81 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $255,058 - $419,802	-22,692 Reduced 7.59%	276,352 $3.49 Million
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $272,312 - $335,053	21,785 Added 7.86%	299,044 $4.59 Million
Q2 2018 Aug 13, 2018	SELL	$7.99 - $14.05 $125,427 - $220,556	-15,698 Reduced 5.36%	277,259 $3.64 Million
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $324,728 - $393,446	-44,914 Reduced 13.29%	292,957 $2.39 Million
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $629,722 - $877,842	-78,519 Reduced 18.86%	337,871 $2.99 Million
Q3 2017 Nov 13, 2017	BUY	$9.11 - $11.26 $3.79 Million - $4.69 Million	416,390	416,390 $4.63 Million

Others Institutions Holding NEO

# of Institutions

276

Shares Held

127M

Call Options Held

581K

Put Options Held

115K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.94B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account